315 - Hot Topics in Outpatient Antimicrobial Therapy of Infective Endocarditis

10/6/2019

8:00 AM - 9:00 AM

Room: Walter E. Washington Convention Center, 206

MOC Credit: Maximum of 1 hours of MOC Credit
CME Credit: Maximum of 1 hours of AMA PRA Category 1 Credit™
ACPE Credit: ACPE 1 knowledge-based contact hours of pharmacy CE
ACPE Number: 0221-9999-19-433-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe the role of oral therapy in outpatient treatment of endocarditis
describe the implications of IV drug use in outpatient management of endocarditis

Presentations:

8:00 AM - 8:30 AM
2910 - Oral Therapy for Infective Endocarditis
Claus Moser, MD, PhD – Rigshospitalet
8:30 AM - 9:00 AM
2911 - Outpatient Antimicrobial Therapy for People Who Inject Drugs (PWID) with Infective Endocarditis (IE)
Steven M. Gordon, MD – Cleveland Clinic Foundation

Moderator(s)

Jose M. Miro, MD, PHD

Senior Consultant / Professor of Medicine
Hosp Clinic - IDIBAPS - Univ. of Barcelona. Barcelona, Spain
Barcelona, Spain

Disclosure: AbbVie, Angelini, Contrafect, Cubist, Genentech, Gilead Sciences, Jansen, Medtronic, MSD, Novartis, Pfizer, and ViiV Healthcare: Advisory Board, Research Grant
VC

Vivian Chu, MD

Duke University
Chapel Hill, North Carolina

Speaker(s)

Steven Gordon, MD

Chairman Department of Infectious Diseases@Steven
Cleveland Clinic Foundation
Cleveland, Ohio

Disclosure: Nothing to disclose
Claus Moser, MD, PhD

Senior consultant
Rigshospitalet
Copenhagen, Denmark

Disclosure: Nothing to disclose